InspireMD (NSPR) Tops Q2 EPS by 19c

InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.24), $0.19 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.8 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
• Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold